52 / 72
13,583 shares of performance based restricted stock which vests on the third anniversary if the 2015 performance metrics are met; and (iii) a grant of options to purchase
21,348 shares of common stock which vest on the third anniversary.
(2)
Includes $441,100 deferred for Mr. Daniel P. Amos. This amount has been included in the 2015 Nonqualified Deferred Compensation table below.
(3)
In accordance with the SEC's reporting requirements, we report all equity awards at their full grant date fair value in accordance with ASC 718. The Company's valuation
assumptions are described in Note 12 “Share-Based Compensation” in the Notes to the Consolidated Financial Statements in the Company’s Annual Form 10-K filed with
the SEC for the year ended December 31, 2015. See page 47 for a more detailed discussion of our outstanding equity grants compared to current fair market value.
The Compensation Committee reduced the contingent February 2015 PBRS grant for Mr. Cloninger by 2,783 shares on December 31, 2015 after the 2015 performance of
the Company was validated. The remaining 49,101 shares had a grant date fair market value of $3,017,256. Additionally, the Compensation Committee reduced the
contingent February 2014 PBRS grant for Mr. Daniel P. Amos by 56,134 shares on December 31, 2014 after the 2014 performance of the Company was validated. The
remaining 34,308 shares had a grant date fair market value of $2,141,162.
(4)
No amount in this column is attributable to above market earnings on deferred compensation. The aggregate change in the actuarial present value of the accumulated
benefit obligation of the defined benefit pension plan and Retirement Plan for Senior Officers for Mr. Daniel P. Amos was a decrease of $7,863,664. Mr. Crawford is not
eligible to participate in the defined benefit plans because the plans were frozen prior to his hire date. See the “Pension Benefits” section and the accompanying table
below beginning on page 50 for a more detailed discussion of the retirement plans.
(5)
Additional information regarding all other compensation is provided in the “All Other Compensation” or “Perquisites” tables detailed below.
(6)
Base salary is typically the smallest component of total compensation for the NEOs as the majority of their total compensation is based on performance awards on a cash
and equity basis. Base salaries (including deferrals) as a percent of total compensation for Messrs. Daniel P. Amos, Crawford, Cloninger, Paul S. Amos II, and Kirsch for
2015 were approximately 12%, 10%, 14%, 12%, and 15%, respectively.
45